GBA1 and Parkinson disease: DNA methylation was consistently lower at all eight sites in PD-GBA1 compared with idiopathic PD, displaying significance at two CpG sites (CpG3, p = 0.0158 and CpG6, p = 0.0498) (Figure 1).